Ameritas Advisory Services’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Ameritas Advisory Services's TGTX Position: Q3 2026 in Review
Ameritas Advisory Services reduced its TG Therapeutics (TGTX) stake by 4.8% in Q3 2026, selling an estimated $541 and leaving 200 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.
Ameritas Advisory Services first reported a position in TGTX in Q1 2023 and has held it in 5 quarters since. The position peaked at $25.5K in Q1 2023. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Ameritas Advisory Services held 200 shares of TG Therapeutics worth $11.2K as of Q3 2026.
- Ameritas Advisory Services sold 10 TG Therapeutics shares in Q3 2026, an estimated $541.
- TG Therapeutics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #1486 holding.
- Ameritas Advisory Services first reported a position in TG Therapeutics in Q1 2023 and has held it in 5 quarters since.
- Ameritas Advisory Services's TG Therapeutics position peaked at $25.5K in Q1 2023.
- 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.